Zurcher Kantonalbank (Zurich Cantonalbank) - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$605,402
-12.9%
12,055
+9.6%
0.00%0.0%
Q2 2023$695,390
+61.3%
11,003
+14.8%
0.00%
+50.0%
Q1 2023$431,094
+0.6%
9,582
-2.0%
0.00%0.0%
Q4 2022$428,462
-15.0%
9,780
+27.9%
0.00%
-33.3%
Q3 2022$504,000
+30.6%
7,6490.0%0.00%
+50.0%
Q2 2022$386,000
-23.6%
7,649
-3.2%
0.00%0.0%
Q1 2022$505,000
-47.7%
7,903
-12.3%
0.00%
-60.0%
Q4 2021$965,000
+45.6%
9,010
+39.7%
0.01%
+25.0%
Q3 2021$663,000
+16.9%
6,449
-0.0%
0.00%
+33.3%
Q2 2021$567,000
-9.3%
6,451
+0.3%
0.00%
-25.0%
Q1 2021$625,000
-18.7%
6,430
-6.3%
0.00%
-20.0%
Q4 2020$769,000
+48.5%
6,860
+22.9%
0.01%
+25.0%
Q3 2020$518,000
+18.8%
5,5840.0%0.00%0.0%
Q2 2020$436,000
+106.6%
5,584
+55.1%
0.00%
+100.0%
Q1 2020$211,000
-9.4%
3,600
+23.9%
0.00%0.0%
Q4 2019$233,000
+8.9%
2,9060.0%0.00%0.0%
Q3 2019$214,000
-4.9%
2,906
+21.8%
0.00%0.0%
Q2 2019$225,000
+17.8%
2,3850.0%0.00%0.0%
Q1 2019$191,000
+21.7%
2,385
-18.0%
0.00%0.0%
Q4 2018$157,000
-30.8%
2,9070.0%0.00%0.0%
Q3 2018$227,000
+22.7%
2,9070.0%0.00%0.0%
Q2 2018$185,000
-16.3%
2,907
+20.4%
0.00%0.0%
Q1 2018$221,000
+56.7%
2,415
+29.4%
0.00%
+100.0%
Q4 2017$141,000
+69.9%
1,866
+57.3%
0.00%0.0%
Q3 2017$83,000
+38.3%
1,1860.0%0.00%0.0%
Q2 2017$60,000
+50.0%
1,186
+18.8%
0.00%
Q1 2017$40,0009980.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders